Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome

Obesity

Volumn 18, Issue 9, 2010, Pages 1871-1874

  Ogawa, Tsuneo ^a   Kawano, Yurika ^b   Imamura, Takuroh ^b   Kawakita, Kumiko ^a   Sagara, Mina ^c   Matsuo, Takeshi ^d   Kakitsubata, Yousuke ^d   Ishikawa, Tadashi ^d   Kitamura, Kazuo ^b   Hatakeyama, Kinta ^b   Asada, Yujiro ^b   Kodama, Tatsuhiko ^e  

^a MINAMI KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c Perseus Proteomics   (Japan)

^d Miyazaki Social Insurance Hospital   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; PENTRAXIN 3; SERUM AMYLOID P; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MORPHOMETRICS; OBESITY; REFERENCE VALUE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY WEIGHTS AND MEASURES; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; HUMANS; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; REFERENCE VALUES; SERUM AMYLOID P-COMPONENT; TRIGLYCERIDES;

EID: 77956094879     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.507     Document Type: Article

References (20)

1. Castell JV, Gomez-Lechon MJ, David M et al. Acute-phase responseof human hepatocytes: regulation of acute-phase protein synthesis byinterleukin-6. Hepatology 1990;12:1179-1186.
2. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. ElevatedC-reactive protein levels in overweight and obese adults. JAMA1999;282:2131-2135.
3. Bottazzi B, Vouret-Craviari V, Bastone A et al. Multimer formation andligand recognition by the long pentraxin PTX3. Similarities and differenceswith the short pentraxins C-reactive protein and serum amyloid Pcomponent. J Biol Chem 1997;272:32817-32823.
4. Lee GW, Lee TH, Vilcek J. TSG-14, a tumor necrosis factor-and IL-1-inducible protein, is a novel member of the pentaxin family of acute phaseproteins. J Immunol 1993;150:1804-1812.
5. Klouche M, Peri G, Knabbe C et al. Modified atherogenic lipoproteinsinduce expression of pentraxin-3 by human vascular smooth muscle cells.Atherosclerosis 2004;175:221-228.
6. Jaillon S, Peri G, Delneste Y et al. The humoral pattern recognition receptorPTX3 is stored in neutrophil granules and localizes in extracellular traps.J Exp Med 2007;204:793-804.
7. Abderrahim-Ferkoune A, Bezy O, Chiellini C et al. Characterization of thelong pentraxin PTX3 as a TNF-induced secreted protein of adipose cells.J Lipid Res 2003;44:994-1000.
8. Tong M, Carrero JJ, Qureshi AR et al. Plasma pentraxin 3 in patients withchronic kidney disease: associations with renal function, protein-energywasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol2007;2:889-897.
9. Suliman ME, Yilmaz MI, Carrero JJ et al. Novel links between the longpentraxin 3, endothelial dysfunction, and albuminuria in early and advancedchronic kidney disease. Clin J Am Soc Nephrol 2008;3:976-985.
10. Inoue K, Sugiyama A, Reid PC et al. Establishment of a high sensitivityplasma assay for human pentraxin3 as a marker for unstable anginapectoris. Arterioscler Thromb Vasc Biol 2007;27:161-167.
11. Peri G, Introna M, Corradi D et al. PTX3, A prototypical long pentraxin,is an early indicator of acute myocardial infarction in humans. Circulation2000;102:636-641.
12. Alberti L, Gilardini L, Zulian A et al. Expression of long pentraxin PTX3 inhuman adipose tissue and its relation with cardiovascular risk factors.Atherosclerosis 2009;202:455-460.
13. Yamasaki K, Kurimura M, Kasai T et al. Determination of physiologicalplasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem LabMed 2009;47:471-477.
14. Suliman ME, Qureshi AR, Carrero JJ et al. The long pentraxin PTX-3 inprevalent hemodialysis patients: associations with comorbidities andmortality. QJM 2008;101:397-405.
15. Bosutti A, Malaponte G, Zanetti M et al. Calorie restriction modulatesinactivity-induced changes in the inflammatory markers C-reactive proteinand pentraxin-3. J Clin Endocrinol Metab 2008;93:3226-3229.
16. Norata GD, Marchesi P, Pirillo A et al. Long pentraxin 3, a key componentof innate immunity, is modulated by high-density lipoproteins in endothelialcells. Arterioscler Thromb Vasc Biol 2008;28:925-931.
17. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidativestress in obesity and its impact on metabolic syndrome. J Clin Invest2004;114:1752-1761.
18. Dias AA, Goodman AR, Dos Santos JL et al. TSG-14 transgenic mice haveimproved survival to endotoxemia and to CLP-induced sepsis. J LeukocBiol 2001;69:928-936.
19. Salio M, Chimenti S, De Angelis N et al. Cardioprotective function ofthe long pentraxin PTX3 in acute myocardial infarction. Circulation2008;117:1055- 1064.
20. Nauta AJ, Bottazzi B, Mantovani A et al. Biochemical and functionalcharacterization of the interaction between pentraxin 3 and C1q.Eur J Immunol 2003;33:465-473.